Navigation Links
Westaim announces sale of iFire Technology Ltd. assets
Date:10/17/2008

CALGARY, Oct. 17 /PRNewswire-FirstCall/ - The Westaim Corporation announced today a purchase and sale agreement between its wholly owned subsidiary iFire Technology Ltd. and CTS Group Limited. Under the agreement, iFire will sell its equipment, patents and intellectual property for net proceeds of approximately US$8.0 million. The sale is subject to several conditions, including iFire obtaining certain Government of Canada consents and approvals, which are expected to be obtained by mid-November. CTS Group is a Canadian-Chinese joint venture with established operations in Henan province, People's Republic of China.

"iFire management has worked very hard over the past few months to bring this transaction to completion," said Drew Fitch, President & CEO of Westaim. "The sale of iFire's assets will provide Westaim with additional cash resources as the company pursues its goal of strategically transitioning into a new sector."

Westaim previously announced it has entered into a reorganization agreement where it will acquire, subject to shareholder approval, several closely held and profitable businesses that provide products and services in the growing western Canadian construction industry. An information circular was mailed to shareholders on October 15th in advance of a special meeting of shareholders to be held on November 21, 2008. Westaim continues to hold a 74.5 percent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS).

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

This news release contains forward-looking statements. These statements are based on current expectations that are subject to risks and uncertainties, and Westaim can give no assurance that these expectations are correct. Various factors could cause actual results to differ materially from those projected in such statements, including but not limited to statements regarding the sale of assets, cash resources to be realized from the sale of assets, shareholder and other approvals to which acquisition of businesses or sales of assets are subject, conditions upon the sale of assets, Westaim's strategic transition to a new sector, and the acquisition of businesses. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise. Accordingly, readers are advised not to place undue reliance on forward-looking statements, and should not rely on this information at any date other than the date of this news release. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim announces 2008 second quarter results
2. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
3. Westaim announces 2008 first quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
5. Westaim announces 2007 year-end results
6. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
7. Westaim reduces ABCP exposure
8. Westaim announces 2007 third quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
10. The Westaim Corporation update on status of short-term investments
11. US Oncologys Innovent Oncology Division Announces First Agreement Between Rocky Mountain Cancer Centers and Colorado Public Employees Retirement Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... ... Will Never Be The Same” is a fictional tale about growing up with the ... the creation of published author, Kim T. Briggs, a self-described “big kid” who has ... and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama skits ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... ability of physical therapist assistants, under direct supervision of a licensed physical therapist, ... physical therapy receives a consultation and treatment plan from a licensed physical therapist ...
(Date:12/5/2016)... IL (PRWEB) , ... December 05, 2016 , ... The ... to the individual looking to buy neoprene knee sleeves for lifting and ... The design focuses heavily on two main aspects to provide a higher quality knee ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... an excellent way to ensure moisture measurements are consistently correct. However, regular ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... they have teamed up with The American College of Surgeons (ACS) to provide ... on Trauma, the “Bleeding Control Basic” course is a pilot program that fulfills ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: